ARF1 (ADP-Ribosylation Factor 1) is a small GTP-binding protein that functions as a molecular switch regulating vesicle trafficking between the endoplasmic reticulum (ER) and the Golgi apparatus. This protein is essential for membrane trafficking, protein sorting, and synaptic function. Dysregulation of ARF1-mediated trafficking has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD).
| ARF1 Protein |
|---|
| Protein Name | ADP-Ribosylation Factor 1 (ARF1) |
| Gene | [ARF1](/genes/arf1) |
| UniProt ID | [P84077](https://www.uniprot.org/uniprot/P84077) |
| PDB ID | 1R8Q, 1R8S, 2J0X |
| Molecular Weight | ~20.6 kDa |
| Subcellular Localization | Golgi apparatus, ER-Golgi intermediate compartment |
| Protein Family | ARF GTPase family |
ARF1 is a small GTP-binding protein with characteristic features:
- GTP-binding domain: Switch between active (GTP-bound) and inactive (GDP-bound) states
- N-terminal myristoylation: Lipid modification for membrane association
- Switch I and II regions: Conformational changes upon GTP/GDP binding
- Effector loop: Mediates interactions with downstream targets
- ArfGAP domain: GTPase-activating protein binding site
- ER-Golgi transport: Regulates COP I vesicle formation
- Golgi maintenance: Essential for Golgi cisternal maturation
- Endosomal trafficking: Controls protein sorting
- Synaptic vesicle recycling: Critical for neurotransmitter release
- Dendritic trafficking: Regulates protein delivery to synapses
- Postsynaptic receptor trafficking: Controls AMPA and GABA receptor localization
- APP trafficking: ARF1 regulates APP movement through secretory pathway
- Amyloid-beta production: Affects BACE1 and gamma-secretase access to APP
- Synaptic vesicle dysfunction: Impairs neurotransmitter release
- Autophagy-lysosomal pathway: Disrupted trafficking affects protein clearance
- Synaptic function: Critical for dopaminergic neuron communication
- Alpha-synuclein trafficking: May affect secretion and aggregation
- Mitochondrial quality control: Impaired ER-mitochondria contacts
- Lysosomal function: Disrupted trafficking to autophagosomes
- Small molecule modulators: Targeting ARF1 activation
- ArfGAP modulators: Indirect ARF1 regulation
- Gene therapy: Restoring proper trafficking
¶ ARF Family and Neurodegeneration
The ARF GTPase family includes:
- ARF1: ER-Golgi trafficking
- ARF3: Golgi function
- ARF5: Redundant with ARF1/3
- ARF6: Endocytosis and actin remodeling
GTPase-activating proteins regulate ARF activity:
- ArfGAP1: Coat disassembly
- ArfGAP2/3: COPI function
- SMAP1/2: Dendritic trafficking
- ArfGAP inhibitors: Modulate ARF cycling
- GTP analogs: Stabilize active/inactive states
- Protein-protein interaction disrupters: Target ARF effectors
- Vesicle trafficking defects: Impaired axonal transport
- TDP-43 pathology: Interactions with ARF1-mediated trafficking
- Motor neuron vulnerability: Specific effects on MN function
- Huntingtin protein interactions: Modulates ARF1 activity
- Vesicle trafficking disruption: Contributes to synaptic dysfunction
- Autophagy impairment: Effects on lysosomal trafficking
- Axonal transport enhancement: Targeting ARF1 cycling
- Gene therapy approaches: Modulating ARF1 expression
- Small molecule modulators: Developing brain-penetrant compounds